半导体核心部件龙头，来了！下周有2只新股申购，北交所、科创板各有1只

Core Viewpoint - The article discusses the upcoming IPOs of two companies, Aisheren and Hengyun Chang, highlighting their business focus, financial performance, and market positions. Group 1: Aisheren - Aisheren is the largest manufacturer of medical care pads in China, focusing on disposable medical consumables for rehabilitation and medical protection [2][7] - The IPO price for Aisheren is set at 15.98 CNY per share, with a price-to-earnings ratio of 14.99 [2][7] - Aisheren's revenue for 2022, 2023, and 2024 is projected to be 574 million CNY, 575 million CNY, and 692 million CNY, respectively, with net profits of 63 million CNY, 67 million CNY, and 81 million CNY [2][7] - The company forecasts a revenue growth of 28.65% to 35.89% and a net profit growth of 10.63% to 22.01% for 2025 [2][7] Group 2: Hengyun Chang - Hengyun Chang is a leading supplier of core components for semiconductor equipment, focusing on plasma RF power systems and related technologies [3][8] - The company plans to issue 16.93 million shares, with a maximum subscription limit of 4,000 shares for online investors [3][8] - Hengyun Chang's revenue for 2022, 2023, and 2024 is projected to be 158 million CNY, 325 million CNY, and 541 million CNY, respectively, with net profits of 26 million CNY, 80 million CNY, and 142 million CNY [3][8] - The company anticipates a revenue decline of 4.69% to 9.58% and a net profit decline of 19.54% to 28.21% for 2025 [3][8] Group 3: Market Context - In 2025, a total of 19 new stocks are expected to be listed on the Sci-Tech Innovation Board, bringing the total number of companies to 600 [4][9] - All 19 new stocks listed in 2025 experienced price increases on their first trading day, with an average increase of 244.37%, and 18 of them saw gains exceeding 100% [4][9] - The most recent listing, Qiangyi Co., had an IPO price of 85.09 CNY per share and a first-day increase of 165.61%, resulting in a profit of 70,500 CNY for a single subscription [4][9]